Molecular Assay Market to Grow at a CAGR of 7% During the Forecast Period (2025 – 2030): Wissen Research

The global molecular assay market was valued at USD 16.4 billion in 2024 and is projected to reach USD 24.6 billion by 2030, expected to grow at a CAGR of 7% during the forecast period, 2025-2030.

Sheridan, Sept. 03, 2025 (GLOBE NEWSWIRE) -- According to the latest market report published by Wissen Research, the global molecular assay market was valued at USD 16.4 billion in 2024. Furthermore, the market is expected to grow at a CAGR of 7% during the forecast period from 2025 to 2030.

Molecular Assays Market Report Pricing @ https://www.wissenresearch.com/Pricing/

Molecular Assays Market Summary

US Molecular Assays Market Size

Furthermore, the US with USD 5.1 billion market in 2024, held the largest share in the global molecular diagnostics market and is likely to show the highest growth at CAGR of 7.2% within this market, during the forecast period (2025-2030).

Growth Drivers

• The need for early and precise diagnostics is being fueled by the rising incidence of infectious and chronic diseases.
• As personalized medicine becomes more widely used, accurate molecular-level insights are required for treatment selection.
• The capabilities and effectiveness of molecular tests are improved by technological developments such as faster sequencing and multiplexing.
• Patient access to molecular diagnostic procedures is being improved by favourable reimbursement policies in a number of regions.

Opportunities

• Entering emerging markets presents substantial unrealized potential for customer base expansion and market growth, particularly in the Asia-Pacific area.
• Better data analysis and clinical decision support could result from growing integration with AI and digital health.
• New opportunities for patient stratification and targeted drug development are presented by expanding pharmacogenomics applications.
• Rapid molecular diagnostics outside of conventional lab settings is made possible by the growth of point-of-care testing (POCT).
  

The molecular diagnostics market, was dominated by infectious disease diagnostics by application type in 2024

In 2024, Infectious disease diagnostics held the largest share of the global molecular diagnostics market by application type. Its dominance stems from several key factor such as the high global prevalence and continuous emergence of infectious diseases creating a persistent testing demand, the critical need for rapid and highly accurate results to guide treatment and infection control, and the significant technological advancements enabling faster pathogen detection compared to traditional methods. Furthermore, the widespread adoption and infrastructure established during the COVID-19 pandemic dramatically accelerated the use of molecular testing for infectious diseases globally. The versatility of molecular technologies (such as PCR, NGS, and isothermal amplification) allows for the detection of a vast range of pathogens (viruses, bacteria, fungi, parasites) directly from various sample types. Additionally, the increasing focus on antimicrobial resistance (AMR) and the essential role of molecular diagnostics in public health surveillance and outbreak management serve as major drivers for this application. 

Polymerase Chain Reaction (Amplification-based technique) are estimated to hold the largest market share in the global molecular diagnostics market by technology in 2025.

In 2025, Amplification-based techniques, particularly Polymerase Chain Reaction (PCR) and its real-time variant (qPCR), are estimated to dominate the global molecular diagnostics market when segmented by technology. This leadership position stems from several key factors: unparalleled sensitivity and specificity for detecting target nucleic acids, even at very low concentrations; well-established protocols and widespread validation across research and clinical settings; and a broad applicability for diagnosing infectious diseases (including COVID-19 and other pathogens), guiding cancer therapy, and performing genetic testing. These techniques offer relatively rapid results compared to some sequencing methods and are highly amenable to automation, enabling high throughput testing crucial for busy clinical laboratories. Furthermore, the extensive literature base, long history of use, and the widespread availability of numerous commercial PCR/qPCR platforms and kits contribute significantly to their enduring market leadership. The continued strength of R&D activities utilizing PCR for various applications, alongside their widespread adoption in clinical diagnostics, infectious disease monitoring, and research, serves as a major driver for this technology segment.   

Asia-pacific is projected to be the fastest-growing segment by region, in the forecast period (2025-2030)

The Asia Pacific molecular diagnostics market is set for strong growth. It is expected to be the fastest growing market in the overall diagnostics sector and will likely outpace any other region globally. This rapid growth results from several factors. Including an increased burden of infectious diseases and chronic conditions, such as various cancers, in the region. This makes highly sensitive and specific molecular diagnostics essential. Additionally, aging populations and changing lifestyles in countries like China, India, Japan, and South Korea raise the prevalence of chronic diseases. These diseases require molecular testing for early detection, screening, and personalized management. Importantly, governments in the Asia Pacific are investing significantly to modernize healthcare systems. They are expanding insurance coverage and implementing national disease control programs with funding for advanced diagnostic capabilities, including molecular testing. At the same time, awareness is growing among clinicians and the public about the benefits of molecular diagnostics. These tools can lead to faster and more accurate diagnoses, better management of infectious diseases (including tracking antimicrobial resistance), and personalized medicine, especially in oncology, where companion diagnostics for targeted therapies are becoming the norm. The region is also quickly adopting new molecular technologies like Next-Generation Sequencing (NGS), Digital PCR (dPCR), and Multiplex PCR. These technologies enable comprehensive genomic profiling, liquid biopsies, and the detection of multiple targets simultaneously. Moreover, the large patient population creates significant demand for diagnostics and positions the region as an attractive hub for global clinical trials. This requires strong support from molecular diagnostics. Support from international bodies, increasing regulatory efforts towards standardization, and more market opportunities are attracting investment. This investment is fostering local manufacturing and driving the introduction of innovative, often cost-effective, molecular biomarker technologies. These technologies are tailored to various healthcare settings, from major urban areas to remote regions. Together, these elements contribute to the dynamic and rapid growth of the molecular diagnostics market in Asia Pacific.

Request Customized Report @ https://www.wissenresearch.com/ask-for-customization/

Contact us for a free sample of the molecular assays market report @ https://www.wissenresearch.com/contact-us/

Other Latest Reports from Wissen Research

• Lateral Flow Assays Market
• Immunoassays Market
• Point of Care Market
• Remote Patient Monitoring Market
• Wearable Technology Market
• In-Vitro Diagnostics Market
• Digital Diabetes Management Market
• Fuel Cell Technology Market
• Veterinary Practice Management Software Market
• Unmanned Aerial Vehicle (Drone) Market
• Industrial Robotics Market

About us

Wissen Research is a leading market research firm that serves over 800 clients, with 40% of the top 2,000 companies relying on us for insights into key business questions and the identification of new high-growth and niche revenue opportunities. We offer exclusive market intelligence from over 120 subject matter experts and analysts, complemented by our high-growth niche market studies and consulting services.

Our research methodology delivers quantifiable and actionable insights into interconnected market ecosystems shaped by disruptive technologies and emerging markets. We not only focus on factors that will impact our clients' revenue but also explore what could affect their customers' revenue by revealing latent and adjacent market opportunities.

We collaborate across all B2B sectors, engaging with C-level executives in areas such as R&D, intellectual property, strategy, marketing, sales, product development, and M&A.

Mayur Jain
Wissen Research LLC
Gould St, Ste R
Sheridan, WY 82801
Phone: (+91) 7814300364
info@wissenresearch.com

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.